In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
ESC Congress 2020 Register

EuroPCR 2020 cancelled due to COVID-19

Interventional Cardiology


EuroPCR 2020 has been cancelled due to COVID-19. The 31st edition of the annual world-leading course in interventional cardiovascular medicine was due to take place in Paris, France on 19-22 May. The sanitary and legal environment, and in particular the decision of the French government barring public gatherings exceeding 5,000 participants, have resulted in this cancellation. EuroPCR is the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology.

Accompanying EuroPCR’s network through unprecedented times: EuroPCR organisers have used the weeks leading up to the announcement to safeguard the interests of the vast network of individuals and organisations that support the annual Course, such as clinicians, allied healthcare professionals, industry partners, hotels, audio-visual providers, caterers and booth builders. Their sustainability through the COVID-19 crisis was at stake.

An additional dedicated online resource during the pandemic: PCR continues to provide free and extensive educational resources throughout the year, on PCRonline. Over the last 2-3 months, sharing of knowledge, experience and practice has remained more relevant than ever.  A newly developed resource on “Facing Covid-19 with PCR” is providing the interventional community with practical content and advice, at a time when the outbreak is seriously complicating the management of their patients.

Ongoing commitment to independent medical education: The Programme Committee has expressed their strong commitment to providing the community with a full update on late-breaking trials and other essential educational work. The details of how this new initiative will be implemented is to be made known in the coming weeks. As for the next edition of EuroPCR, it is set to take place in Paris, France on 18-21 May 2021.

ENDS

 

Notes to editor

About EuroPCR

EuroPCR is the World-Leading Course in interventional cardiovascular medicine and the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology. It has been gathering the interventional cardiovascular community annually since 1989.  A total of 11,206 participants were present at the 30th anniversary edition in May 2019, and an additional 4,700 online learners connected to watch a selection of sessions that were made available both live and on replay via PCR Virtual Event on PCRonline.com.

About PCR

The mission of PCR is to serve the needs of each individual patient by helping the cardiovascular community to share knowledge, experience and practice. PCR offers a large range of many other educational meetings and resources for the continuing education of the interventional cardiovascular community. These include major annual Courses across the globe, e-Learning with high-profile PCR Webinars, Courses specifically dedicated to valvular heart disease, tailor-made PCR Seminars on specific topics, online resources and medical publications such as EuroIntervention, the official journal of the EAPCI.

About EAPCI

EAPCI was created in 2006 with objectives and activities stemming from the synergy between the assets of EuroPCR and the former ESC Working Group on Interventional Cardiology. Postgraduate education, improvements of patient access to device-based therapies, and promotion of clinical research represent obvious areas of common interest.

 

For further information, please contact Célia Vilà: cvila@europa-group.com